<DOC>
	<DOCNO>NCT01877785</DOCNO>
	<brief_summary>This randomize , double-blind , placebo-controlled , single-ascending dose study assess safety , tolerability pharmacokinetics ascend dos MHAA4549A healthy volunteer . Volunteers randomize receive single dose MHAA4549A match placebo .</brief_summary>
	<brief_title>A Study MHAA4549A Assess Safety And Pharmacokinetics Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy volunteer Body mass index ( BMI ) 18 32 kg/m2 , inclusive Weight 40 100 kg In good health , determine clinically significant finding medical history , 12lead ECG , vital sign Clinical laboratory evaluation within reference range test laboratory unless deem clinically significant investigator Sponsor Volunteers agree use acceptable contraceptive measure History clinically significant manifestation disorder History anaphylaxis , hypersensitivity drug allergy History presence abnormal ECG History significant alcohol abuse within 1 year prior screen regular use alcohol within 6 month prior screen visit History significant drug abuse within 1 year prior screen Current tobacco smoker Positive drug screen screen checkin Positive pregnancy test result screen Day 1 breast feeding study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>